Study of the efficiency of a peptide-based cosmetic product in topical therapy for diffuse alopecia

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background: Hair loss is a significant health problem; hence, individuals experiencing hair loss immediately visit a doctor for treatment. Diffuse (symptomatic) alopecia can be the result of various external and internal factors. A doctor should determine the cause of the hair loss and prescribe treatment, including topical agents.

Aim: to study the clinical efficacy of hair spray with peptides in the treatment of patients with diffuse alopecia and its effect on the trichogramma parameters.

Materials and methods: Thirty female patients with diffuse alopecia, aged from 18 to 59 years, were monitored in the Center of Medical Cosmetology of the I.I. Mechnikov North-Western State Medical University. In a controlled comparative study, the patients were divided into two equal groups. In group 1 (main), the drug of choice was a spray based on peptides; while in group 2 (comparison), a cosmetic product based on enzymes was applied. The drugs were used topically for 3 months. Patients were examined using questionnaires (objective assessment by the doctor and subjective evaluation by the patient) and photographs and by assessing the morphometric parameters of hair growth before treatment, 3 months after the start of treatment, and 1 month after treatment termination.

Results: In group 1, in the parietal zone, the hair density increased significantly by 19% after 3 months and by 23% after 4 months. The number of anagen hair increased by 8% after 3 months and by 16% after 4 months, with a corresponding decrease in the number of telogen hair compared to the initial level. In the occipital zone, the number of anagen hair increased by 7% after 3 months and by 13% after 4 months, with the corresponding dynamics of telogen hair compared to the initial level. The cosmetic product has been shown to be tolerated well, and no allergic reactions were noted.

Conclusion: The peptide-based spray can be recommended for patients with diffuse alopecia as a topical therapy.

Full Text

Restricted Access

About the authors

Tatiana N. Korolkova

North-Western State Medical University n.a. I.I. Mechnikov

Author for correspondence.
Email: tnkor@mail.ru
ORCID iD: 0000-0001-7190-411X

MD, PhD, DSc, Professor, Head of the Department of Cosmetology of North-Western State Medical University n.a. I.I. Mechnikov

Russian Federation, St Petersburg

E. E. Kharitonova

North-Western State Medical University n.a. I.I. Mechnikov

Email: tnkor@mail.ru
ORCID iD: 0000-0001-5838-5466
Russian Federation, St Petersburg

I. A. Shepilova

North-Western State Medical University n.a. I.I. Mechnikov

Email: tnkor@mail.ru
ORCID iD: 0000-0002-4147-9789
Russian Federation, St Petersburg

D. S. Nesterovich

Vernadsky Institute of Geochemistry and Analytical Chemistry

Email: tnkor@mail.ru
ORCID iD: 0000-0003-3837-9362
Russian Federation, Moscow

References

  1. Batkaeva EA, Gallyamova YuA, Khassan Al’-khadzh Khaled. Diffuse alopecia: Methodical Manual. Moscow: Russian Medical Academy of Postgraduate Education; 2010. (in Russian)
  2. Zlotogorsky A, Shapiro J. Trichology. Transl. from Engl. Kiev: Rodovshch; 2016. (in Russian)
  3. Dribnokhod YuYu. Hair treatment in cosmetology. St. Petersburg: SpetsLit; 2015. (in Russian)
  4. Adaskevich VP, Myadelets OD, Tikhonovskaya IV. Alopecia. Moscow: Medical book; 2000. (in Russian)
  5. Uryupina EL, Malishevskaya NP. The condition of the psychoemotional status in patients with diffuse telogen hair loss. Russian Journal of Skin and Venereal Diseases. 2017;20(5):285-9. (in Russian)
  6. Simbirtsev AS. Prospects for the use of preparations of cytokines in dermatovenereology. Practical Medicine. Russian Journal. 2011;49(2):15-2. (in Russian)

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Results of subjective assessment of the use of drugs for the treatment of diffuse alopecia.

Download (171KB)
3. Fig. 2. The results of an objective assessment of the use of drugs for the treatment of diffuse alopecia.

Download (153KB)
4. Fig. 3. Patient N., 39 years old. Dynamics of hair density in the parietal zone: a - before treatment; b - 3 months after the start of treatment; c - 4 months after the start of treatment. Uv. 60.

Download (252KB)

Copyright (c) 2020 Eco-Vector



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 86501 от 11.12.2023 г
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 80653 от 15.03.2021 г
.



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies